CORT

Corcept Therapeutics Incorporated NCM · CORT

$93.89 +2.32 (+2.53%)

Extended · +1.60σ

+ Compare Open in Sniper

Valuation

Market cap $9.8B

P/E (ttm) 254.4

Forward P/E 28.6

Beta (5y) 0.46

Shares out 107.4M

Div yield —

Profitability & returns

ROE 7.2%

Net margin 6.2%

FCF margin 15.0%

Debt / equity 0.02

Trading information

Last price $93.89

Day range $91.21 – $94.49

52-wk range $28.66 – $95.11

Avg volume 1.1M

RSI (2) 95.2

Trend zone Extended

52-week range · today's price

$28.66$95.11

Company

Sector Healthcare

Industry Biotechnology

Exchange NCM

Next earnings 2026-07-30

Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus o…